Indian pharmaceutical company Bravo Pharmaceuticals Pvt. Ltd. Started construction of the plant on production of ready medicaments at the special industrial-economic zone “Navoi”.
Bravo Pharmaceuticals, registered at SIEZ Navoi, will produce medical products in line with the WHO EU GMP standard.
The project’s cost is about US$2.6 million. The project will provide jobs for 100 people once it is commissioned for exploitation.
Within the project, it is planned to localize production with gradual increasing its share.
The company will produce more than 30 kinds of innovative drugs, including for patients with cancer. The plant will start its operations in 14 months.